Technology News and Research

RSS

Researcher uses biopharmaceutical proteases to develop novel therapy for Alzheimer's disease

A University of Oklahoma researcher is developing a novel therapy for Alzheimer's disease using "biopharmaceutical proteases" to attack the toxic plaque that builds up in the brain of an Alzheimer's patient-an approach that he predicts will be lower in cost and higher in effectiveness than current therapies.

9 Jul 2010

MU researchers refine EHR technology to efficiently meet increasing health care demands

In 20 years, approximately 72 million older adults will reside in the United States, almost double the current number, according to the U.S. Administration on Aging. Potential issues are compounded by the projected shortage of health care workers needed to provide elder care. As part of the solution, an interdisciplinary team of University of Missouri researchers is refining electronic health record (EHR) technology to more efficiently meet increasing health care demands.

9 Jul 2010

UKPTO grants arGEN-X patent covering SIMPLE Antibody platform

arGEN-X, a biopharmaceutical company focused on the discovery and development of human monoclonal antibodies using its proprietary SIMPLE Antibody(TM) platform, announces that it has been granted the first patent covering the platform. The patent GB2461546B, has been granted by the UK Patent and Trademark Office (UKPTO).

9 Jul 2010

IBC offers more personalized online information about PHR to its members

Independence Blue Cross now offers its members more personalized online information about their health – as the amazon.com experience is to the savvy shopper, the ibxpress.com experience is to the smart health care consumer. Personal health information began to flow into members' electronic health records this month – available through ibxpress.com, the company's member website.

9 Jul 2010

Patients enrolled in CLARITY-AF study

Biosense Webster, Inc., a worldwide leader in the diagnosis and treatment of cardiac arrhythmias, announces that more than 10 patients have now been enrolled in the CLARITY-study, comparing the efficacy, safety and efficiency of CARTO 3 System guided radiofrequency ablation using the NAVISTAR THERMOCOOL catheter versus fluoroscopy guided radiofrequency ablation using the Pulmonary Vein Ablation catheter (Ablation Frontiers, Medtronic) in patients with paroxysmal atrial fibrillation.

9 Jul 2010

Study finds EUS associated with improved outcomes in patients with localized pancreatic cancer

A new study has found that endoscopic ultrasound (EUS) is associated with improved outcomes in patients with localized pancreatic cancer, possibly due to the detection of earlier cancers and improved stage-appropriate management, including more selective performance of curative intent surgery. This is the first study to analyze a large population-based cancer registry and demonstrate that EUS evaluation is associated with improved pancreatic cancer survival.

9 Jul 2010

Haemonetics settles patent infringement suit against STRADIS-MED

Haemonetics GmbH today announced settlement of its pending legal action against STRADIS-MED GmbH and its General Manager, Jochen Kirchner, for the infringement of two German utility models of Haemonetics (DE 200 10 825 U1 and DE 203 10 937 U1) related to Haemonetics' plasma technology.

9 Jul 2010

NeuroPace submits PMA to FDA for world's first responsive neurostimulation system

NeuroPace, Inc. today announced that it has submitted its Premarket Approval (PMA) application to the U.S. Food and Drug Administration (FDA) for its RNS® System, a novel investigational device that utilizes responsive neurostimulation to monitor and interrupt abnormal electrical activity in the brain before seizures occur. The PMA application is for an indication to treat people with medically refractory partial onset epilepsy originating from one or two locations in the brain.

9 Jul 2010

Biomagnetics, LANL collaborate to develop device for tuberculosis diagnosis

Biomagnetics Diagnostics Corp., a developer of revolutionary technology for diagnostic systems for HIV, hepatitis, tuberculosis and malaria detection, today announced the signing of an agreement with Los Alamos National Security, LLC where Los Alamos National Laboratory's scientific and engineering staffs will attempt to identify new potential human tuberculosis biomarkers and will develop a validated assay to detect human tuberculosis using a currently known biomarker to be used in combination with the waveguide-based optical biosensor platform.

9 Jul 2010

VBA acquires BISNet software from ClearBenefits

Vantage Benefits Administrators (VBA) is proud to announce the acquisition of the BISNet software and all its Intellectual Property from ClearBenefits, Inc. to strategically enhance our Unified Point of Service administration offerings. BISNet, Inc., a fully owned subsidiary of Vantage Benefits Administrators, will reemerge as a world class benefits enrollment and administration system provider on July 15, 2010.

9 Jul 2010

iPierian announces closing of $22M Series B equity financing round

iPierian, Inc., the leading biopharmaceutical company using patient-derived induced pluripotent stem cells (iPSCs) for drug discovery, today announced the closing of a $22 million Series B equity financing. The financing round was led by new investor Google Ventures, and was joined by Mitsubishi UFJ Capital and ATEL Ventures. All current investors also participated, including: Kleiner Perkins Caufield & Byers, Highland Capital Partners, MPM Capital and FinTech Global Capital.

9 Jul 2010

ITelagen to provide EHR, outsourced billing and IT support for Canterbury Medical Associates

ITelagen, a leading provider of Healthcare IT solutions, was selected by Christ Hospital to provide electronic health records (EHR) as part of an entire back-office solution that includes outsourced billing and unlimited IT support for their affiliate Canterbury Medical Associates.

9 Jul 2010

PharmAthene reports progress in lyophilized rPA anthrax vaccine development program

PharmAthene, Inc., a biodefense company developing medical countermeasures against biological and chemical threats, announced today that it continues to make solid progress in its lyophilized recombinant Protective Antigen (rPA) anthrax vaccine development program. The Company has recently demonstrated that its lyophilized rPA vaccine candidate is structurally stable and potent at various temperatures up to and including 70 degrees centigrade.

9 Jul 2010

Eurofins MWG Operon, Genomatix Software partner to offer next-gen sequencing solutions

Eurofins MWG Operon, an expert in next generation sequencing (NGS) and Genomatix Software GmbH, a leading company in complex analysis and interpretation of such NGS data, announce their decision to combine their expertise and join forces to offer state-of-the art solutions for comprehensive genome analysis and re-sequencing project services.

9 Jul 2010

Roche Molecular Systems receives FDA clearance for new LightCycler MRSA Advanced Test

Roche Molecular Systems, Inc. announced today that the U.S. Food & Drug Administration (FDA) cleared its new LightCycler® MRSA Advanced Test for the detection of methicillin-resistant Staphylococcus aureus (MRSA) for clinical use in the United States.

9 Jul 2010

Onda celebrates 2000th hydrophone shipment

Onda Corporation, the global leader in ultrasound measurements, celebrated the 2000th hydrophone shipment. The hallmark unit, a polymer-based HNP hydrophone, shipped to St. Jude's Medical where it is used to test the acoustic properties of their medical transducers in production.

8 Jul 2010

pSivida submits MAA for Iluvien to UK MHRA

pSivida Corp., a leader in the development of sustained release back of the eye drug delivery systems for difficult-to-treat conditions, today announced that its licensee, Alimera Sciences has submitted a Marketing Authorization Application (MAA) to the Medicines and Healthcare Products Regulatory Agency (MHRA) in the United Kingdom (UK) for Iluvien®.

8 Jul 2010

PhotoMedex receives multi-million dollar order from AMICO Group to purchase XTRAC laser systems

PhotoMedex, Inc. announced that the Company has received from AMICO Group, its distributor in the Middle East, a multi-million dollar order to purchase XTRAC laser systems that will be installed in hospitals throughout the Kingdom of Saudi Arabia. The order includes customary terms and conditions, including advanced payments and letters of credit covering the purchase order. Delivery is expected to be in the third and fourth quarters of this year.

8 Jul 2010

Calithera Biosciences completes Series A financing totaling $40M

Calithera Biosciences, a company developing novel oncology therapeutics, today announced the completion of a Series A financing totaling $40 million. Morgenthaler Ventures led the financing with U.S. Venture Partners, Advanced Technology Ventures, Delphi Ventures and Mission Bay Capital also participating in the round. The capital will be used to support the company's pioneering efforts to develop activators of caspases, the proteases that promote apoptotic cell death, for the treatment of cancer and other proliferative diseases.

8 Jul 2010

WSBI, University of Colorado sign licensing agreement for TCISM targets

Western States Biopharmaceuticals, Inc., a privately-held biotechnology company focusing on the development of novel therapies to treat inflammatory disease, and the University of Colorado announced today that they have entered into a licensing agreement for approaches to inhibiting newly discovered T cell Cytokine Inducing Surface Molecules, or TCISM autoimmune disease drug discovery targets.

8 Jul 2010

Technology News and Research

Researcher uses biopharmaceutical proteases to develop novel therapy for Alzheimer's disease

MU researchers refine EHR technology to efficiently meet increasing health care demands

UKPTO grants arGEN-X patent covering SIMPLE Antibody platform

IBC offers more personalized online information about PHR to its members

Patients enrolled in CLARITY-AF study

Study finds EUS associated with improved outcomes in patients with localized pancreatic cancer

Haemonetics settles patent infringement suit against STRADIS-MED

NeuroPace submits PMA to FDA for world's first responsive neurostimulation system

Biomagnetics, LANL collaborate to develop device for tuberculosis diagnosis

VBA acquires BISNet software from ClearBenefits

iPierian announces closing of $22M Series B equity financing round

ITelagen to provide EHR, outsourced billing and IT support for Canterbury Medical Associates

PharmAthene reports progress in lyophilized rPA anthrax vaccine development program

Eurofins MWG Operon, Genomatix Software partner to offer next-gen sequencing solutions

Roche Molecular Systems receives FDA clearance for new LightCycler MRSA Advanced Test

Onda celebrates 2000th hydrophone shipment

pSivida submits MAA for Iluvien to UK MHRA

PhotoMedex receives multi-million dollar order from AMICO Group to purchase XTRAC laser systems

Calithera Biosciences completes Series A financing totaling $40M

WSBI, University of Colorado sign licensing agreement for TCISM targets

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News